Symbols

Symbols

KTTA

KTTA

Pasithea Therapeutics Activates New Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients.

Wednesday Sep 17, 2025

Pasithea Therapeutics Expands NF1 Study in South Korea, Leverages Significant Patient Population.

Tuesday Sep 16, 2025

Pasithea Therapeutics Activates South Korean Clinical Trial Sites for PAS-004 Study

Pasithea Therapeutics Activates Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients

Monday Sep 08, 2025

Pasithea Therapeutics: Phase 1/1b Study Proceeds to Cohort 2 Without Modification

Pasithea Therapeutics' Phase 1/1b Clinical Trial for PAS-004 in Adult NF1 Patients Continues with Positive Safety Review Committee Recommendation

Friday Aug 29, 2025

Pasithea Therapeutics Updates Presentation Date at H.C. Wainwright Conference.

Pasithea Therapeutics Updates Conference Presentation Timing

Thursday Aug 28, 2025

Pasithea Therapeutics to Present at H.C. Wainwright Annual Global Investment Conference

Pasithea Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Thursday Jul 31, 2025

Pasithea Therapeutics Completes Enrollment and Initial Dosing of First Cohort in Phase 1/1b Trial for PAS-004 in Adult NF1 Patients.

Friday Jun 27, 2025

Pasithea Therapeutics Receives Nasdaq Delisting Notice for Minimum Bid Price Non-Compliance

Wednesday Jun 11, 2025

Pasithea Therapeutics Appoints Dr. James Lee to Scientific Advisory Board

Monday Jun 09, 2025

Super X Ai's 15min Chart Triggers MACD Death Cross, Bearish Marubozu Alert

Crypto Trader Makes 54x Gain with $171K Investment in $KTA Tokens

Keeta Investor Reaps 5,400% Return, Keeps 6 Million Coins Unsold

Top 5 Cryptocurrencies That Surged This Week: Vice Token, Lagrange, Keeta, Diverge Loop, and Raven

Sunday Jun 08, 2025

Whale Invests $1.18 Million in KTA Holdings, Boosting Market Confidence

Keeta Network's KTA Token Surges 39% to $5.98B Market Cap Amid Regulatory Concerns

Tuesday Jun 03, 2025

Tactile Systems Technology Unveils Promising Cancer Treatment Data at ASCO Meeting